Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Patient Preference Study of Fluticasone Furoate vs Mometasone Furoate in Allergic Rhinitis
NCT02397915Phase 4Completed
- Sponsor
- GSK
- Start
- Mar 2015
- Primary completion
- Jun 2015
- Modality
- Orthosteric Ligands
- Countries
- 4
01
Overview
Phase 4, randomised, double-blind trial of fluticasone in allergic rhinitis (AR) (2 arms), sponsored by GSK. Primary endpoint: Number of Participants With Overall Preference for Nasal Spray Assessed by Preference Questionnaire. Started Mar 2015; status: completed.
02
Drugs
fluticasone
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT02397915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02397915.